Evaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment

The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...

5 days ago
Oncology,Clinical Development,Precision and Personalised Medicine,News

Evaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment

The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...

5 days ago

Innovations in Oncology Today: An Interview with Jessicca Rege

Even aside from the COVID-19 pandemic, 2020 saw a number of innovations in the oncology space, from novel cytokine development to use of NGS to further patient-centric treatment. We spoke to Jessicca Rege, Vice President and Head of Oncology at...

2 weeks ago
Oncology,R&D,Clinical Development,Biology,News

Innovations in Oncology Today: An Interview with Jessicca Rege

Even aside from the COVID-19 pandemic, 2020 saw a number of innovations in the oncology space, from novel cytokine development to use of NGS to further patient-centric treatment. We spoke to Jessicca Rege, Vice President and Head of Oncology at...

2 weeks ago

Immunotherapy and biomarkers: Developments in Combination Therapy for Cancer

Immunotherapy and Biomarkers: Developments in Combination Therapy for Cancer  Over the past few years, increasing evidence has supported the role of biomarkers in immunotherapy. Combination therapy - the use of a combination of products or modalities to treat cancer -...

2 weeks ago
Oncology,R&D,Clinical Development,Biology

Immunotherapy and biomarkers: Developments in Combination Therapy for Cancer

Immunotherapy and Biomarkers: Developments in Combination Therapy for Cancer  Over the past few years, increasing evidence has supported the role of biomarkers in immunotherapy. Combination therapy - the use of a combination of products or modalities to treat cancer -...

2 weeks ago

Innovations in Oncology: An Interview with Raluca Budiu-Predoiu

“These are exciting times for all areas of oncology.” With new advances across the oncological board, from immuno-oncology and biomarkers, it is important to keep up with and understand the latest innovations. We spoke to Raluca Budiu-Predoiu, Translational Oncology Principal...

1 month ago
Oncology,R&D,Precision and Personalised Medicine,News

Innovations in Oncology: An Interview with Raluca Budiu-Predoiu

“These are exciting times for all areas of oncology.” With new advances across the oncological board, from immuno-oncology and biomarkers, it is important to keep up with and understand the latest innovations. We spoke to Raluca Budiu-Predoiu, Translational Oncology Principal...

1 month ago

Broadening the Scope of Therapeutic Treatment – Advancements in Cancer Clinical Trials

With ground-breaking advancements in oncology like check-point inhibitors comes the extensive development of human clinical trials, prioritising patient safety and drug tolerability through pharmacovigilance. Proventa spoke to Chief Medical Officer for Xilio Therapeutics, Martin Huber, for his thoughts regarding exciting...

1 month ago
Oncology,Clinical Development,News

Broadening the Scope of Therapeutic Treatment – Advancements in Cancer Clinical Trials

With ground-breaking advancements in oncology like check-point inhibitors comes the extensive development of human clinical trials, prioritising patient safety and drug tolerability through pharmacovigilance. Proventa spoke to Chief Medical Officer for Xilio Therapeutics, Martin Huber, for his thoughts regarding exciting...

1 month ago

Key Challenges in Oncology and Bioinformatics

This year, Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Oncology/Bioinformatics events,...

8 months ago
Oncology,R&D,Bioprocess,AI & ML,Biology,News

Key Challenges in Oncology and Bioinformatics

This year, Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Oncology/Bioinformatics events,...

8 months ago

R&D: The Impact of AI in 2020

Whenever Proventa holds a Strategy Meeting around the world - regardless of meeting topic - the subject of AI comes up. It really is so important in pharma right now, with the potential to solve some of the sector's big...

1 year ago
Oncology,R&D,Bioinformatics,Biology,News

R&D: The Impact of AI in 2020

Whenever Proventa holds a Strategy Meeting around the world - regardless of meeting topic - the subject of AI comes up. It really is so important in pharma right now, with the potential to solve some of the sector's big...

1 year ago

Weekly News Round-up – 14/2/20

The U.S. Institute for Clinical and Economic Review’s (ICER’s) methods could see legal challenges in the near future, a think tank has warned, due to discrimination against disabled individuals. In other news, Novartis’ rare lung cancer drug capmatinib will be...

1 year ago
Oncology,Bioprocess,Clinical Development,Weekly Roundups,Biology

Weekly News Round-up – 14/2/20

The U.S. Institute for Clinical and Economic Review’s (ICER’s) methods could see legal challenges in the near future, a think tank has warned, due to discrimination against disabled individuals. In other news, Novartis’ rare lung cancer drug capmatinib will be...

1 year ago

The Changing Role of the Blockbuster Drug

There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...

1 year ago
Oncology,R&D,Biology,News

The Changing Role of the Blockbuster Drug

There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...

1 year ago

Weekly News Round-up – 17/1/20

The week passed fairly uneventfully this time, with the baffling politics and shocking events of the new decade struggling to get started. Instead, research from Scottish universities indicated a link between a type of common gut bacteria and Parkinson's; a...

1 year ago
Oncology,Weekly Roundups,Biology

Weekly News Round-up – 17/1/20

The week passed fairly uneventfully this time, with the baffling politics and shocking events of the new decade struggling to get started. Instead, research from Scottish universities indicated a link between a type of common gut bacteria and Parkinson's; a...

1 year ago